DMWD Antikörper (C-Term)
Kurzübersicht für DMWD Antikörper (C-Term) (ABIN2254187)
Target
Alle DMWD Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 518-545, C-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- DMWD, CT (DMWD, DM9, Dystrophia myotonica WD repeat-containing protein, Dystrophia myotonica-containing WD repeat motif protein, Protein 59, Protein DMR-N9)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- DMWD antibody is generated from rabbits immunized with a KLH conjugated synthetic between 518-545 amino acids selected from the C-terminal region of human DMWD.
-
Isotyp
- IgG
-
-
anti-Dystrophia Myotonica, WD Repeat Containing (DMWD) (AA 245-334) antibody
DMWD Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 3F5 unconjugated
anti-Dystrophia Myotonica, WD Repeat Containing (DMWD) (AA 519-545), (C-Term) antibodyDMWD Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB38751 unconjugated
anti-Dystrophia Myotonica, WD Repeat Containing (DMWD) (AA 509-558) antibodyDMWD Reaktivität: Human, Maus, Ratte, Rind (Kuh), Meerschweinchen, Pferd, Fledermaus, Affe WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
-
